FDA finds more bogus Avastin in U.S. supply chain

02/7/2013 | HealthDay News · Yahoo

Counterfeit versions of bevacizumab, which is sold in the U.S. as Genentech's Avastin, has entered the U.S. drug supply chain, according to a warning from the FDA. The bogus drug is labeled as Roche Holding's Altuzan. That drug is not approved for sale in the U.S. Testing found one or more batches of the suspect drug lacked the active ingredient, and the fake products are linked to Medical Device King, Pharmalogical and Taranis Medical.

View Full Article in:

HealthDay News · Yahoo